We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Remote Magnetic Navigation For Cavotricuspid Isthmus Ablation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00560872
Recruitment Status : Completed
First Posted : November 20, 2007
Last Update Posted : December 23, 2009
Information provided by:
University Hospital Goettingen

Brief Summary:
The purpose of this study is to evaluate the influence of remote magnetic catheter navigation on the safety and efficacy of mapping and radiofrequency ablation of the cavotricuspid isthmus in patients with typical atrial flutter.

Condition or disease Intervention/treatment
Atrial Flutter Device: remote magnetic catheter navigation Procedure: cavotricuspid isthmus ablation

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Randomized Controlled Study of Remote Magnetic Catheter Navigation for Cavotricuspid Isthmus Mapping and Ablation in Patients With Typical Atrial Flutter
Study Start Date : August 2007
Primary Completion Date : December 2008
Study Completion Date : June 2009

Arm Intervention/treatment
conventional ablation with manual catheter navigation
Procedure: cavotricuspid isthmus ablation
conventional (manual) approach
Active Comparator: 2
ablation with remote magnetic catheter navigation
Device: remote magnetic catheter navigation
use of the Stereotaxis system

Primary Outcome Measures :
  1. ablation duration and fluoroscopy time [ Time Frame: 3 months ]

Secondary Outcome Measures :
  1. total procedure duration, success, ablation characteristics, flutter recurrence, complications [ Time Frame: 6 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • ECG documentation of at least 1 episode of typical atrial flutter

Exclusion Criteria:

  • Prior right atrial ablation
  • Ferromagnetic implants that may interfere with the magnetic navigation system
  • Pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00560872

Herzzentrum, Abteilung Kardiologie, Georg-August-Universitaet
Goettingen, Germany, 37075
Sponsors and Collaborators
University Hospital Goettingen
Principal Investigator: Dirk Vollmann, PD Dr. med. Herzzentrum, Abteilung Kardiologie, Universitaetsmedizin Goettingen

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: PD Dr. med. Dirk Vollmann, Universitaetsmedizin Goettingen, Germany
ClinicalTrials.gov Identifier: NCT00560872     History of Changes
Other Study ID Numbers: MN-07-022-GOE
First Posted: November 20, 2007    Key Record Dates
Last Update Posted: December 23, 2009
Last Verified: December 2009

Keywords provided by University Hospital Goettingen:
atrial flutter

Additional relevant MeSH terms:
Atrial Flutter
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes